When John Hibbs' daughter Xanthe received her first bank card in the mail, the six-year-old spent the next week Googling how to buy a horse.
Shipping group Maersk on Wednesday reported third-quarter sales and operating profit in line with previous guidance and maintained its earnings forecast.
Airlines are scrambling to prepare ultra-cold shipping and storage facilities to transport COVID-19 vaccines developed by Pfizer and Moderna, whose doses, which require deep freezing, are likely to be among the first to be distributed.
Owners of Swiss luxury group Richemont have approved plans to issue warrants as part of a shareholder loyalty scheme, the company said on Wednesday, setting out terms for the issue that follows a COVID-19 related cut to the dividend.
Berkshire Hathaway Inc's new bet on the U.S. pharmaceutical industry signals hope for shares of large drug companies, which have lagged a broad market rally amid concern about efforts to rein in prescription drug prices.
After nearly two years of scrutiny, corporate upheaval and a standoff with global regulators, Boeing Co is set on Wednesday to win approval from the U.S. Federal Aviation Administration to fly its 737 MAX jet again after two fatal disasters.
Any final exit by Britain from the European Union that worsens business conditions through increased tariffs would threaten the sustainability of Nissan Motor Co's UK operations, the Japanese car maker's chief operating officer (COO) cautioned.
SINGAPORE: Foreign visitors to Singapore can now buy inbound travel insurance coverage for COVID-19-related costs incurred in Singapore, the Changi Airport Group (CAG) and the Singapore Tourism Board (STB) said on Wednesday (Nov 18). The announcement was made on behalf of the Emerging Stronger ...
Facebook Inc Chief Executive Mark Zuckerberg told U.S. senators on Tuesday that a page which posted a "call to arms" during protests in Kenosha, Wisconsin, in August had not violated the company's "call to arms" policy.
Asian equities were set for a sluggish open on Wednesday, tracking a lower Wall Street session as concerns over rising coronavirus cases and fresh lockdowns dampened the euphoria from vaccine trial breakthroughs.
